Stock Quote
Medtronic, Inc. (MDT.N) (New York Stock Exchange)
$40.29
10:24am EST
+1.69%
$39.62
$40.00
332,100
$40.46
$39.91
$40.22
$24.06
0.71
5,532,042
MDT.N
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Hawkins, William | Chairman of the Board, Chief Executive Officer | 7,512,630 |
| Ellis, Gary | Chief Financial Officer, Senior Vice President | 3,323,980 |
| Webster, Brian | President - Physio-Control | -- |
Profile
Medtronic, Inc. (Medtronic) is a global player in medical technology. The Company operates in seven segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control.... Full Description
Company Address
Medtronic, Inc.
710 Medtronic Parkway
LC-480
Minneapolis MN 55432
P: +1763.5052692
F: +1763.5146272
710 Medtronic Parkway
LC-480
Minneapolis MN 55432
P: +1763.5052692
F: +1763.5146272
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Boston Scientific Corporation | $8.15 | +0.06 |
| St. Jude Medical, Inc. | $34.83 | +0.51 |
| Zimmer Holdings, Inc. | $58.09 | +1.17 |
| MDT.N | Industry | |
|---|---|---|
| P/E(TTM) | 23.79 | 7.62 |
| P/S(TTM) | 2.96 | 0.46 |
| ROI(TTM) | 9.46 | 0.98 |
| ROE(TTM) | 14.71 | 1.52 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | 2.93 |
| Total Revenue | $3,933.00M |
| Net Income | $445.00M |
| EPS | $0.40 |
